With Veeva Link for Key People, LEO Pharma is looking to deepen its efforts to engage with knowledgeable medical professionals in the dermatology community.
Takeda is in talks to sell Shire’s experimental inflammatory bowel disease pipeline in an effort to meet European regulators approval for the acquisition.
Recipharm says it will cease manufacturing at sites in Stockholm and Höganäs, citing ‘underperforming operations’ at its package filling and manufacturing-focused sites.
The contract sales and marketing business will reach $5.2bn (€4bn)
by 2011, as it represents an ideal outsourcing opportunity for
pharma companies competing in this fast growing sector, according
to new market research.
PDI, who provides sales and marketing services to the
pharmaceutical industry, have received a new sales representative
contract in the US from GlaxoSmithKline (GSK), worth $65-70m
(€55-59m).
Building on a stronger start to the year, Germany's third largest
chemicals group reports continued growth into the second quarter
with an increase in demand pushing up sales and earnings.
Chemicals company Rhodia has played down reports in the French
press that it is considering a sell-off of its activities in
silicon, food additives and phosphates as part of an asset
divestment programme aimed at improving its profitability.